MX2020009900A - Formulaciones peptidicas especificas para el receptor de melanocortinas y metodos para un suministro especifico en el tubo gastrointestinal. - Google Patents
Formulaciones peptidicas especificas para el receptor de melanocortinas y metodos para un suministro especifico en el tubo gastrointestinal.Info
- Publication number
- MX2020009900A MX2020009900A MX2020009900A MX2020009900A MX2020009900A MX 2020009900 A MX2020009900 A MX 2020009900A MX 2020009900 A MX2020009900 A MX 2020009900A MX 2020009900 A MX2020009900 A MX 2020009900A MX 2020009900 A MX2020009900 A MX 2020009900A
- Authority
- MX
- Mexico
- Prior art keywords
- specific
- gastrointestinal tract
- methods
- melanocortin receptor
- peptide formulations
- Prior art date
Links
- 102000004378 Melanocortin Receptors Human genes 0.000 title abstract 3
- 108090000950 Melanocortin Receptors Proteins 0.000 title abstract 3
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000001189 Cyclic Peptides Human genes 0.000 abstract 1
- 108010069514 Cyclic Peptides Proteins 0.000 abstract 1
- 102000008314 Type 1 Melanocortin Receptor Human genes 0.000 abstract 1
- 108010021428 Type 1 Melanocortin Receptor Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862647000P | 2018-03-23 | 2018-03-23 | |
| PCT/US2019/023575 WO2019183472A1 (en) | 2018-03-23 | 2019-03-22 | Melanocortin receptor-specific peptide formulations and methods for gastrointestinal tract-specific delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020009900A true MX2020009900A (es) | 2021-01-08 |
Family
ID=67988087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020009900A MX2020009900A (es) | 2018-03-23 | 2019-03-22 | Formulaciones peptidicas especificas para el receptor de melanocortinas y metodos para un suministro especifico en el tubo gastrointestinal. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220088146A1 (https=) |
| EP (1) | EP3768245A4 (https=) |
| JP (1) | JP2021523931A (https=) |
| KR (1) | KR102743821B1 (https=) |
| CN (1) | CN112188888A (https=) |
| AU (2) | AU2019239300A1 (https=) |
| BR (1) | BR112020019128A2 (https=) |
| CA (1) | CA3095036A1 (https=) |
| EA (1) | EA202092275A1 (https=) |
| IL (1) | IL277496B2 (https=) |
| MX (1) | MX2020009900A (https=) |
| PH (1) | PH12020551596A1 (https=) |
| WO (1) | WO2019183472A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115515617A (zh) * | 2020-02-03 | 2022-12-23 | 帕拉丁科技公司 | 二胺连接的受体特异性环状肽 |
| JPWO2024143501A1 (https=) * | 2022-12-28 | 2024-07-04 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7645459B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
| FR2937868B1 (fr) * | 2008-11-04 | 2010-11-05 | Galderma Res & Dev | Composes antagonistes des recepteurs de la melanocortine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique |
| EP2440572B1 (en) * | 2009-06-08 | 2017-04-05 | Palatin Technologies, Inc. | Lactam-bridged melanocortin receptor-specific peptides |
| CA2761607C (en) * | 2009-06-08 | 2018-09-04 | Yi-Qun Shi | Melanocortin receptor-specific peptides |
| JP5999702B2 (ja) * | 2009-11-23 | 2016-09-28 | パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. | メラノコルチン−１受容体特異的環状ペプチド |
| US8759386B2 (en) * | 2011-01-24 | 2014-06-24 | Boehringer Ingelheim International Gmbh | Pyrazole compounds as CRTH2 antagonists |
| BR112013027222B1 (pt) * | 2011-06-14 | 2022-07-12 | Ipsen Pharma S.A.S. | Composição de liberação sustentada que contém peptídeos como ingrediente ativo |
| EP3187171B1 (en) * | 2012-04-30 | 2024-09-25 | Tillotts Pharma AG | A delayed release drug formulation |
| UA119335C2 (uk) * | 2013-12-11 | 2019-06-10 | Айронвуд Фармасьютикалз, Інк. | Композиції лінаклотиду з затриманим вивільненням |
| US20150306230A1 (en) * | 2014-04-28 | 2015-10-29 | Celanese Acetate Llc | Drug delivery vehicles comprising cellulose derivatives, starch derivatives, and combinations thereof |
| US10588864B2 (en) * | 2016-03-11 | 2020-03-17 | Gateway Pharmaceuticals LLC | Pharmaceutical compositions for colon-specific delivery |
-
2019
- 2019-03-22 CA CA3095036A patent/CA3095036A1/en active Pending
- 2019-03-22 CN CN201980034318.2A patent/CN112188888A/zh active Pending
- 2019-03-22 BR BR112020019128-0A patent/BR112020019128A2/pt not_active Application Discontinuation
- 2019-03-22 EP EP19771187.2A patent/EP3768245A4/en active Pending
- 2019-03-22 MX MX2020009900A patent/MX2020009900A/es unknown
- 2019-03-22 JP JP2021500503A patent/JP2021523931A/ja active Pending
- 2019-03-22 AU AU2019239300A patent/AU2019239300A1/en not_active Abandoned
- 2019-03-22 KR KR1020207030569A patent/KR102743821B1/ko active Active
- 2019-03-22 IL IL277496A patent/IL277496B2/en unknown
- 2019-03-22 WO PCT/US2019/023575 patent/WO2019183472A1/en not_active Ceased
- 2019-03-22 EA EA202092275A patent/EA202092275A1/ru unknown
-
2020
- 2020-09-22 US US17/028,437 patent/US20220088146A1/en not_active Abandoned
- 2020-09-22 PH PH12020551596A patent/PH12020551596A1/en unknown
-
2025
- 2025-02-19 AU AU2025201154A patent/AU2025201154A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019183472A1 (en) | 2019-09-26 |
| CA3095036A1 (en) | 2019-09-26 |
| BR112020019128A2 (pt) | 2021-01-12 |
| IL277496B2 (en) | 2025-01-01 |
| US20220088146A1 (en) | 2022-03-24 |
| EP3768245A1 (en) | 2021-01-27 |
| PH12020551596A1 (en) | 2021-08-16 |
| KR102743821B1 (ko) | 2024-12-18 |
| KR20210003759A (ko) | 2021-01-12 |
| EA202092275A1 (ru) | 2021-02-09 |
| AU2019239300A1 (en) | 2020-11-19 |
| CN112188888A (zh) | 2021-01-05 |
| IL277496A (en) | 2020-11-30 |
| JP2021523931A (ja) | 2021-09-09 |
| AU2025201154A1 (en) | 2025-03-13 |
| IL277496B1 (en) | 2024-09-01 |
| EP3768245A4 (en) | 2023-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020551742A1 (en) | Gip derivatives and uses thereof | |
| PH12020500241A1 (en) | Cytokine conjugates for the treatment of autoimmune diseases | |
| PH12020500500A1 (en) | Pyrazolopyrimidinone compounds and uses thereof | |
| MX356295B (es) | Análogos de péptido de la hormona de estimulación de alfa-melanocito. | |
| MX2017015493A (es) | Andamiajes de la subunidad a de la toxina shiga desinmunizados y moleculas con direccion a las celulas que los comprenden. | |
| MX394873B (es) | Sistemas y metodo para suministro de gas terapeutico a pacientes en necesidad del mismo usando la medicion de flujo de gas de circuito de respiracion (bcg) mejorada | |
| GEP20217326B (en) | Constructs having a sirp-alpha domain or variant thereof | |
| PH12020551018A1 (en) | Oral delivery of glp-1 peptide analogs | |
| ES2722799T3 (es) | Vacunas contra el cáncer de cerebro basadas en el péptido alfa 2 del receptor de interleuquina-13 | |
| EA201390194A1 (ru) | Улучшенный рекомбинантный фолликул-стимулирующий гормон человека | |
| MX2015015249A (es) | Peptidos terapeuticos. | |
| ZA202103867B (en) | Tubulysins and protein-tubulysin conjugates | |
| WO2017093810A3 (en) | Composition for intraoral delivery of biologically active peptides and proteins | |
| MX2019013801A (es) | Compuestos de citocina inhibidora de macrofagos-1 (mic-1) y usos de estos. | |
| PH12020551596A1 (en) | Melanocortin receptor-specific peptide formulations and methods for gastrointestinal tract-specific delivery | |
| CL2015002620A1 (es) | Derivados piridin-4-ilo | |
| MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
| MX2009013682A (es) | Enlazador de fmoc polimerico hidrolizable. | |
| CR20210545A (es) | Formas sólidas de un inhibidor de glyt1 | |
| EA201700019A1 (ru) | Высокочистый оритаванцин и способ его получения | |
| EP3530671A3 (en) | Gip peptide analogues | |
| PH12020552071A1 (en) | Btnl3/8 targeting constructs for delivery of payloads to the gastrointestinal system | |
| MX2021004924A (es) | Administracion oral de celulas terapeuticas de mamiferos. | |
| MX2020013389A (es) | Composiciones de terlipresina y usos de las mismas. | |
| PH12022551990A1 (en) | Diamine-linked receptor-specific cyclic peptides |